It is found in the study that PDIA3 was expressed in all types of tumors, with the lowest expression in brain lower grade glioma (LGG) and the highest expression in prostate adenocarcinoma (PRAD) in order of expression level from lowest to highest (Figure 1(c)). The gene discussed is PDIA3; the disease is central nervous system cancer.